Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025European PsychiatryOpen Access

Transcranial Pulse Stimulation (TPS) suitable add-on treatment of patients with psychiatric disorders?

View Full Paper
Ask AI
Bookmark
Share

Authors

VRV. Rößner-RuffCPC. A. PenkovJKJulia Krieger

Discussion

Loading...

Member takes

Overview

Observational analysis showed cognitive performance improved and depressive symptoms reduced in patients with Alzheimer's, suggesting TPS as a potential treatment option.

Key Points

  • Cognitive performance in Alzheimer's patients showed a significant increase with TPS treatment over six months.
  • Depressive symptoms were reduced significantly from a mean score of 9.5 to 6.8, indicating TPS may effectively target ADHD-related issues.
  • This longitudinal study evaluated TPS's impact on cognitive and depressive outcomes in patients with mild to moderate Alzheimer’s disease.
  • Further research is essential due to a small sample size and lack of control conditions, which limits the broader applicability of the findings.

Cite This Study

Rößner-Ruff et al. (2025) studied this question.

synapsesocial.com/papers/68d454d131b076d99fa5a5bchttps://doi.org/10.1192/j.eurpsy.2025.1634
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Transcranial pulse stimulation in Alzheimer's disease2023 · 23 citations
  2. 2602. RESEARCH ON TRANSCRANIAL PULSE STIMULATION (TPS) IN MAJOR DEPRESSIVE DISORDER (MDD)2025
  3. 3Transcranial Pulse Stimulation in Alzheimer’s: Long-Term Feasibility and a Multifocal Treatment Approach2025
  4. 4New therapeutic option for treatment-resistant depression using transcranial pulse stimulation: real-world data from a case series2025
  5. 5Neuronavigated Transcranial Pulse Stimulation (TPS) with shock waves as a novel tool of noninvasive brainstimulation (NIB) for a long-term treatment of Alzheimer’s disease2025